DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

Myriad Genetics Q2 Adj. EPS $0.23 Misses $0.31 Estimate, Sales $195.1M Miss $209.81M Estimate

Myriad Genetics (NASDAQ:MYGN) reported quarterly earnings of $0.23 per share which missed the analyst consensus estimate of $0.31 by 25.81 percent. This is a 39.47 percent decrease over earnings of $0.38 per share from

Benzinga · 02/06/2020 21:20

Myriad Genetics (NASDAQ:MYGN) reported quarterly earnings of $0.23 per share which missed the analyst consensus estimate of $0.31 by 25.81 percent. This is a 39.47 percent decrease over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $195.1 million which missed the analyst consensus estimate of $209.81 million by 7.01 percent. This is a 10.01 percent decrease over sales of $216.8 million the same period last year.